BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 12883042)

  • 1. Pharmacogenetics of ATP-binding cassette transporters in cancer and chemotherapy.
    Lockhart AC; Tirona RG; Kim RB
    Mol Cancer Ther; 2003 Jul; 2(7):685-98. PubMed ID: 12883042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenomics of ABC transporters and its role in cancer chemotherapy.
    Sparreboom A; Danesi R; Ando Y; Chan J; Figg WD
    Drug Resist Updat; 2003 Apr; 6(2):71-84. PubMed ID: 12729805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ATP-binding cassette transmembrane transporters and their epigenetic control in cancer: an overview.
    Arrigoni E; Galimberti S; Petrini M; Danesi R; Di Paolo A
    Expert Opin Drug Metab Toxicol; 2016 Dec; 12(12):1419-1432. PubMed ID: 27459275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphisms of the drug transporters ABCB1, ABCG2, ABCC2 and ABCC3 and their impact on drug bioavailability and clinical relevance.
    Bruhn O; Cascorbi I
    Expert Opin Drug Metab Toxicol; 2014 Oct; 10(10):1337-54. PubMed ID: 25162314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic polymorphisms of ATP-binding cassette transporters ABCB1 and ABCC2 and their impact on drug disposition.
    Haufroid V
    Curr Drug Targets; 2011 May; 12(5):631-46. PubMed ID: 21039333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of resistance to anticancer drugs: the role of the polymorphic ABC transporters ABCB1 and ABCG2.
    Lepper ER; Nooter K; Verweij J; Acharya MR; Figg WD; Sparreboom A
    Pharmacogenomics; 2005 Mar; 6(2):115-38. PubMed ID: 15882131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenetics of ATP-binding cassette transporters and clinical implications.
    Cascorbi I; Haenisch S
    Methods Mol Biol; 2010; 596():95-121. PubMed ID: 19949922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mouse ATP-Binding Cassette (ABC) Transporters Conferring Multi-Drug Resistance.
    Li S; Zhang W; Yin X; Xing S; Xie HQ; Cao Z; Zhao B
    Anticancer Agents Med Chem; 2015; 15(4):423-32. PubMed ID: 25929575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of pharmacogenetics of ATP-binding cassette transporters in the pharmacokinetics of drugs.
    Cascorbi I
    Pharmacol Ther; 2006 Nov; 112(2):457-73. PubMed ID: 16766035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multidrug resistance: molecular mechanisms and clinical relevance.
    Ling V
    Cancer Chemother Pharmacol; 1997; 40 Suppl():S3-8. PubMed ID: 9272126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multidrug resistance: genes, polymorphisms, biologic effects, reversal and treatment in cancer chemotherapy.
    Aragon-Ching JB
    Anticancer Agents Med Chem; 2010 Oct; 10(8):582. PubMed ID: 21244347
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacogenetics of membrane transporters: a review of current approaches.
    Sissung TM; Gardner ER; Gao R; Figg WD
    Methods Mol Biol; 2008; 448():41-62. PubMed ID: 18370230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ABC transporter superfamily. An updated overview, relevance in cancer multidrug resistance and perspectives with personalized medicine.
    Juan-Carlos PM; Perla-Lidia PP; Stephanie-Talia MM; Mónica-Griselda AM; Luz-María TE
    Mol Biol Rep; 2021 Feb; 48(2):1883-1901. PubMed ID: 33616835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy-induced resistance by ATP-binding cassette transporter genes.
    Gillet JP; Efferth T; Remacle J
    Biochim Biophys Acta; 2007 Jun; 1775(2):237-62. PubMed ID: 17572300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenomic importance of ABCG2.
    Cusatis G; Sparreboom A
    Pharmacogenomics; 2008 Aug; 9(8):1005-9. PubMed ID: 18681776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human ABC transporter ABCG2 in cancer chemotherapy and pharmacogenomics.
    Ishikawa T; Nakagawa H
    J Exp Ther Oncol; 2009; 8(1):5-24. PubMed ID: 19827267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenetics/genomics of membrane transporters in cancer chemotherapy.
    Huang Y
    Cancer Metastasis Rev; 2007 Mar; 26(1):183-201. PubMed ID: 17323126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacogenetics of ABC and SLC transporters in metastatic colorectal cancer patients receiving first-line FOLFIRI treatment.
    De Mattia E; Toffoli G; Polesel J; D'Andrea M; Corona G; Zagonel V; Buonadonna A; Dreussi E; Cecchin E
    Pharmacogenet Genomics; 2013 Oct; 23(10):549-57. PubMed ID: 24018773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Drug resistance mediated by ABC transporters].
    Yoshikawa M; Ito A; Ishikawa T; Ikegami Y
    Gan To Kagaku Ryoho; 2004 Jan; 31(1):1-6. PubMed ID: 14750312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multidrug resistance: retrospect and prospects in anti-cancer drug treatment.
    Pérez-Tomás R
    Curr Med Chem; 2006; 13(16):1859-76. PubMed ID: 16842198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.